Signaturefd, LLC Precigen, Inc. Transaction History

Signaturefd, LLC

$5.4 Billion
Q2 2025

A detailed history of Signaturefd, LLC transactions in Precigen, Inc. stock. As of the latest transaction made, Signaturefd, LLC holds 677 shares of PGEN stock, worth $1,238. This represents 0.0% of its overall portfolio holdings.

Number of Shares

677

Holding current value

$1,238

% of portfolio

0.0%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 16, 2025	BUY	$1.17 - $1.62 $792 - $1,096	677 New	677 $0
Q3 2023 Nov 03, 2023	BUY	$1.08 - $1.85 $12,157 - $20,825	11,257 New	11,257 $15,000
Q3 2022 Nov 08, 2022	BUY	$1.41 - $2.79 $768 - $1,520	545 New	545 $1,000
Q1 2022 May 02, 2022	SELL	$1.91 - $3.98 $278 - $581	-146 Closed	0 $0
Q4 2021 Jan 25, 2022	BUY	$3.53 - $5.5 $515 - $803	146 New	146 $1,000
Q1 2021 Apr 30, 2021	SELL	$6.74 - $10.95 $2,696 - $4,380	-400 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$3.75 - $10.56 $1,500 - $4,224	400 New	400 $4,000
Q2 2020 Jul 30, 2020	SELL	$2.16 - $5.46 $233 - $589	-108 Closed	0 $0
Q1 2020 Apr 23, 2020	BUY	$1.46 - $7.19 $157 - $776	108 New	108 $0

Others Institutions Holding PGEN

# of Institutions

153

Shares Held

164M

Call Options Held

1.11M

Put Options Held

36.8K

Third Security, LLC

83.5M
Shares

$153 Million
73.5% of portfolio
Patient Capital Management, LLC Baltimore, MD

17.4M
Shares

$31.8 Million
1.48% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

11.3M
Shares

$20.6 Million
0.03% of portfolio
Black Rock Inc. New York, NY

10.2M
Shares

$18.8 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

8.8M
Shares

$16.1 Million
0.0% of portfolio

View Full List

About PRECIGEN, INC.

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $381M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

More about PGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.

Account